1. Home
  2. DERM
  3. DERM News

Latest Journey Medical Corporation (DERM) News on November 19, 2025

Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics
DERM

Zacks

6 days ago

Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics

Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates
DERM

Zacks

6 days ago

Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates

Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
DERM

GlobeNewswire

6 days ago

Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

What To Expect From Journey Medical Corp (DERM) Q3 2025 Earnings
DERM

GuruFocus.com

8 days ago

What To Expect From Journey Medical Corp (DERM) Q3 2025 Earnings

electroCore, Inc. (ECOR) Reports Q3 Loss, Beats Revenue Estimates
DERM

Zacks

13 days ago

electroCore, Inc. (ECOR) Reports Q3 Loss, Beats Revenue Estimates

Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025
DERM

GlobeNewswire

14 days ago

Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025

OmniAb, Inc. (OABI) Reports Q3 Loss, Misses Revenue Estimates
DERM

Zacks

14 days ago

OmniAb, Inc. (OABI) Reports Q3 Loss, Misses Revenue Estimates

Journey Medical Corporation to Participate in October 2025 Investor Conferences
DERM

GlobeNewswire

a month ago

Journey Medical Corporation to Participate in October 2025 Investor Conferences

DERM

MT Newswires

4 months ago

Journey Medical's Emrosi Coverage Jumps to 65% of U.S. Commercial Lives

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™
DERM

GlobeNewswire

4 months ago

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™

DERM

MT Newswires

5 months ago

Journey Medical to Join Russell 2000, Russell 3000 Indexes

Journey Medical to Join Russell 2000® and Russell 3000® Indexes
DERM

GlobeNewswire

5 months ago

Journey Medical to Join Russell 2000® and Russell 3000® Indexes

Journey Medical announces data analysis from Phase 3 trials of Emrosi
DERM

TipRanks

5 months ago

Journey Medical announces data analysis from Phase 3 trials of Emrosi

Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference
DERM

GlobeNewswire

5 months ago

Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference

Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV
DERM

GlobeNewswire

5 months ago

Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV

Will Tesla have to play catch up to Waymo's robotaxis?
DERM

Yahoo Finance Video

6 months ago

Will Tesla have to play catch up to Waymo's robotaxis?

Why Scott Bessent wants to make it easier for banks to own Treasurys
DERM

Yahoo Finance

6 months ago

Why Scott Bessent wants to make it easier for banks to own Treasurys

Statement by Minister Guilbeault on Portuguese Heritage Month
DERM

CNW Group

6 months ago

Statement by Minister Guilbeault on Portuguese Heritage Month

Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population
DERM

PR Newswire

6 months ago

Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population

DERM

GlobeNewswire

6 months ago

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
DERM

GlobeNewswire

6 months ago

EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry

Man Utd sign Brazil forward Cunha from Wolves
DERM

AFP

6 months ago

Man Utd sign Brazil forward Cunha from Wolves

‘All the crypto cowboys are gone’: Kevin O’Leary says the sector is safe now and is backing stablecoins
DERM

Moneywise

6 months ago

‘All the crypto cowboys are gone’: Kevin O’Leary says the sector is safe now and is backing stablecoins

DERM

GuruFocus.com

6 months ago

Journey Medical Corp (DERM) Q1 2025 Earnings Call Highlights: Amrosi Launch Boosts Margins ...

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
DERM

GlobeNewswire

6 months ago

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates
DERM

Zacks

6 months ago

Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
DERM

GlobeNewswire

6 months ago

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

What To Expect From Journey Medical Corp (DERM) Q1 2025 Earnings
DERM

GuruFocus.com

6 months ago

What To Expect From Journey Medical Corp (DERM) Q1 2025 Earnings

The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates
DERM

Zacks

6 months ago

The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025
DERM

GlobeNewswire

6 months ago

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025

Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength?
DERM

Zacks

6 months ago

Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength?

Why Journey Medical Corporation (DERM) is Surging in 2025
DERM

Insider Monkey

7 months ago

Why Journey Medical Corporation (DERM) is Surging in 2025

Journey Medical (DERM) Moves 16.8% Higher: Will This Strength Last?
DERM

Zacks

7 months ago

Journey Medical (DERM) Moves 16.8% Higher: Will This Strength Last?

Is Journey Medical Corporation (DERM) a Cheap Hot Stock to Buy Right Now?
DERM

Insider Monkey

7 months ago

Is Journey Medical Corporation (DERM) a Cheap Hot Stock to Buy Right Now?

Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains?
DERM

Zacks

7 months ago

Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains?

DERM

MT Newswires

8 months ago

Journey Medical Promotes Ramsey Alloush to COO

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer
DERM

GlobeNewswire

8 months ago

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

Journey Medical Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
DERM

Simply Wall St.

8 months ago

Journey Medical Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

DERM

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Journey Medical Corp Earnings Call

DERM

GuruFocus.com

8 months ago

Journey Medical Corp (DERM) Q4 2024 Earnings Call Highlights: Strategic Launch of Emrosi and ...

Journey Medical Corporation (DERM) Tops Q4 Earnings Estimates
DERM

Zacks

8 months ago

Journey Medical Corporation (DERM) Tops Q4 Earnings Estimates

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
DERM

GlobeNewswire

8 months ago

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corp (DERM) Q4 2024 Earnings Report Preview: What To Expect
DERM

GuruFocus.com

8 months ago

Journey Medical Corp (DERM) Q4 2024 Earnings Report Preview: What To Expect

Journey Medical launches Emrosi for the treatment of rosacea
DERM

TipRanks

8 months ago

Journey Medical launches Emrosi for the treatment of rosacea

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea
DERM

GlobeNewswire

8 months ago

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025
DERM

GlobeNewswire

8 months ago

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

Journey Medical Corporation to Participate in the 37th Annual ROTH Conference
DERM

GlobeNewswire

8 months ago

Journey Medical Corporation to Participate in the 37th Annual ROTH Conference

Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea
DERM

GlobeNewswire

8 months ago

Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea

Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida
DERM

GlobeNewswire

9 months ago

Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida

Journey Medical Corporation (DERM): A Bull Case Theory
DERM

Insider Monkey

9 months ago

Journey Medical Corporation (DERM): A Bull Case Theory

Journey Medical Corporation's (NASDAQ:DERM) biggest owners are public companies who got richer after stock soared 32% last week
DERM

Simply Wall St.

9 months ago

Journey Medical Corporation's (NASDAQ:DERM) biggest owners are public companies who got richer after stock soared 32% last week

Minot Light Capital’s Largest Performance Detractor in Q4: Journey Medical (DERM)
DERM

Insider Monkey

10 months ago

Minot Light Capital’s Largest Performance Detractor in Q4: Journey Medical (DERM)

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
DERM

GlobeNewswire

10 months ago

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

Despite Journey Medical's Pullback, Insiders Still Gained US$118k
DERM

Simply Wall St.

a year ago

Despite Journey Medical's Pullback, Insiders Still Gained US$118k

Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates
DERM

Zacks

a year ago

Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
DERM

GlobeNewswire

a year ago

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

FDA approves Journey Medical’s rosacea treatment Emrosi
DERM

Pharmaceutical Technology

a year ago

FDA approves Journey Medical’s rosacea treatment Emrosi

DERM

MT Newswires

a year ago

Journey Medical Gets FDA Approval for Rosacea Treatment

Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock?
DERM

Zacks

a year ago

Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock?

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
DERM

GlobeNewswire

a year ago

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
DERM

GlobeNewswire

a year ago

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

DERM

ACCESSWIRE

a year ago

SWK Holdings Provides Portfolio Update

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
DERM

GlobeNewswire

a year ago

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Can Journey Medical Corporation (NASDAQ:DERM) Improve Its Returns?
DERM

Simply Wall St.

a year ago

Can Journey Medical Corporation (NASDAQ:DERM) Improve Its Returns?

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
DERM

GlobeNewswire

a year ago

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
DERM

GlobeNewswire

a year ago

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Journey Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
DERM

Simply Wall St.

a year ago

Journey Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Journey Medical Corporation (NASDAQ:DERM) Just Reported And Analysts Have Been Lifting Their Price Targets
DERM

Simply Wall St.

a year ago

Journey Medical Corporation (NASDAQ:DERM) Just Reported And Analysts Have Been Lifting Their Price Targets

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
DERM

GlobeNewswire

a year ago

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation (DERM) Reports Q2 Loss, Tops Revenue Estimates
DERM

Zacks

a year ago

Journey Medical Corporation (DERM) Reports Q2 Loss, Tops Revenue Estimates

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
DERM

GlobeNewswire

a year ago

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Oncternal Therapeutics (ONCT) Reports Q2 Loss, Tops Revenue Estimates
DERM

Zacks

a year ago

Oncternal Therapeutics (ONCT) Reports Q2 Loss, Tops Revenue Estimates

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024
DERM

GlobeNewswire

a year ago

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
DERM

ACCESSWIRE

a year ago

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

4D Molecular Therapeutics (FDMT) Moves 11.1% Higher: Will This Strength Last?
DERM

Zacks

a year ago

4D Molecular Therapeutics (FDMT) Moves 11.1% Higher: Will This Strength Last?

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors
DERM

GlobeNewswire

a year ago

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

Public companies are Journey Medical Corporation's (NASDAQ:DERM) biggest owners and were rewarded after market cap rose by US$26m last week
DERM

Simply Wall St.

a year ago

Public companies are Journey Medical Corporation's (NASDAQ:DERM) biggest owners and were rewarded after market cap rose by US$26m last week

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
DERM

GlobeNewswire

2 years ago

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

DERM

GuruFocus.com

2 years ago

Journey Medical Corp (DERM) (Q1 2024) Earnings Call Transcript Highlights: Navigating Growth ...

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
DERM

GlobeNewswire

2 years ago

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
DERM

GlobeNewswire

2 years ago

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
DERM

GlobeNewswire

2 years ago

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

DERM

ACCESSWIRE

2 years ago

Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
DERM

GlobeNewswire

2 years ago

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

Director Justin Smith Acquires 30,000 Shares of Journey Medical Corp (DERM)
DERM

GuruFocus.com

2 years ago

Director Justin Smith Acquires 30,000 Shares of Journey Medical Corp (DERM)

Journey Medical Full Year 2023 Earnings: EPS Misses Expectations
DERM

Simply Wall St.

2 years ago

Journey Medical Full Year 2023 Earnings: EPS Misses Expectations

DERM

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Journey Medical Corp Earnings Call

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
DERM

GlobeNewswire

2 years ago

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA
DERM

Zacks

2 years ago

Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
DERM

GlobeNewswire

2 years ago

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
DERM

GlobeNewswire

2 years ago

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
DERM

GlobeNewswire

2 years ago

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
DERM

GlobeNewswire

2 years ago

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting

Journey Medical Insiders Up US$187k On US$520.8k Investment
DERM

Simply Wall St.

2 years ago

Journey Medical Insiders Up US$187k On US$520.8k Investment

Journey Medical (DERM) to Report Q4 Earnings: What's in the Cards?
DERM

Zacks

2 years ago

Journey Medical (DERM) to Report Q4 Earnings: What's in the Cards?

Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B
DERM

Zacks

2 years ago

Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B

Community West Bancshares Reports Full Year Earnings and Declares Quarterly Cash Dividend of $0.08 Per Common Share
DERM

GlobeNewswire

2 years ago

Community West Bancshares Reports Full Year Earnings and Declares Quarterly Cash Dividend of $0.08 Per Common Share

Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.
DERM

PR Newswire

2 years ago

Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.

Bay Commercial Bank (BCML) Lags Q4 Earnings Estimates
DERM

Zacks

2 years ago

Bay Commercial Bank (BCML) Lags Q4 Earnings Estimates

West Bancorp Inc (WTBA) Reports Decline in Annual Net Income Amid Margin Challenges
DERM

GuruFocus.com

2 years ago

West Bancorp Inc (WTBA) Reports Decline in Annual Net Income Amid Margin Challenges

Share on Social Networks: